The AUD/USD pair remains resilient, despite a retreat from recent highs. The Australian Dollar benefits from a weaker US Dollar, as market participants focus on the Fed’s anticipated policy meeting on Wednesday.
At the start of the week, Goldman analysts and others told clients that Tesla's market share in China has remained stable, and the world's second-largest economy has recently overtaken the U.S. as Tesla's largest market.
It was a boring day, with the market falling to start and basically trading sideways. Tomorrow, of course, will be the FOMC meeting, and I do not expect anything material to come from it.
Specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 4.3% year on year to $149.8 million. On the other hand, the company’s full-year revenue guidance of $615 million at the midpoint came in 1.6% below analysts’ estimates. Its GAAP loss of $0.21 per share was significantly below analysts’ consensus estimates.
Global professional services company Jacobs Solutions (NYSE:J) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 2.2% year on year to $2.91 billion. Its non-GAAP profit of $1.48 per share was 6.9% above analysts’ consensus estimates.
Health insurance company Clover Health (NASDAQ:CLOV) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 33.3% year on year to $462.3 million. Its GAAP loss of $0 per share was significantly above analysts’ consensus estimates.
Higher education company Grand Canyon Education (NASDAQ:LOPE) announced better-than-expected revenue in Q1 CY2025, with sales up 5.3% year on year to $289.3 million. The company expects next quarter’s revenue to be around $240.3 million, close to analysts’ estimates. Its GAAP profit of $2.52 per share was 2.9% above analysts’ consensus estimates.
Senior living provider The Pennant Group (NASDAQ:PNTG) announced better-than-expected revenue in Q1 CY2025, with sales up 33.7% year on year to $209.8 million. Its non-GAAP profit of $0.27 per share was 13.7% above analysts’ consensus estimates.
Aerospace and defense company Cadre (NYSE:CDRE) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 5.6% year on year to $130.1 million. The company’s full-year revenue guidance of $633 million at the midpoint came in 5.8% above analysts’ estimates. Its GAAP profit of $0.23 per share was 91.7% above analysts’ consensus estimates.
